Powered By Bing

Supplementary Information

Gene Expression Profiling of Pediatric Acute Myelogenous Leukemia

Section V: Outcome Analysis

Table S17. Patient outcome data used in test set

Case identifier Studya Relapseb No Relapsec
inv16- #04 AML91 - 3402
inv16- #07 AML97 - 1474
MLL- #02 AML87 - 4036
MLL- #06 AML91 - 3092
MLL- #07 AML91 - 2720
MLL- #13 AML91 - 62
MLL- #15 AML97 - 1577
MLL- #20 AML91 223 -
MLL- #22 AML97 - 1565
Other- #01 AML87 0 -
Other- #09 AML87 595 -
Other- #14 AML91 642 -
Other- #17 AML91 182 -
Other- #22 AML91 - 2108
Other- #23 AML97 233 -
Other- #29 AML97 - 1592
Other- #30 AML97 0 -
Other- #32 AML97 - 157
Other- #34 AML87 0 -
Other- #37 AML97 268 -
Other- #39 AML97 324 -
Other- #42 AML97 - 381
Other-M7- #01 AML87 0 -
Other-M7-#07 AML91 0 -
t(8;21)- #02 AML87 425 -
t(8;21)- #05 AML87 0 -
t(8;21)- #07 AML97 - 14
t(8;21)- #10 AML97 291 -
t(8;21)- #19 AML97 - 891
t(8;21)- #20 AML87 340 -

a Treatment protocols: AML87, AML91, AML97 are St.Jude Children’s Research Hospital institutional protocols.
b Shown is the number of days from diagnosis to relapse.   “0” indicates that the patient never achieved a complete remission.
c Shown is the number of days from diagnosis to the last follow-up